Article Information
History
- August 30, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nan-Nan Tiana,b,1,
- Ling-Ling Renb,c,1,
- Ya-Xuan Zhua,b,1,
- Jing-Ya Sund,1,
- Jun-Lan Lua,b,
- Jia-Kai Zengb,
- Feng-Qing Wangb,
- Fei-Fei Dub,
- Xi-He Yangb,c,
- Shu-Ning Ged,
- Rui-Min Huangd,***,
- Wei-Wei Jiab,** and
- Chuan Lia,b,c,e,*
- aGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China
- bState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
- cSchool of Pharmacy, University of Chinese Academy of Sciences, Beijing, 100049, China
- dCenter for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
- eHaihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China
- ↵*Corresponding author. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. E-mail addresses: chli{at}simm.ac.cn (C. Li)
- ↵**Corresponding author. E-mail addresses: weiweijia{at}simm.ac.cn (W-W. Jia)
- ↵***Corresponding author. E-mail addresses: rmhuang{at}simm.ac.cn (R-M. Huang)
↵1 These authors contributed equally to this work.